A Sanger sequencing protocol for SARS-CoV-2 S-gene
- PMID: 34346163
- PMCID: PMC8447197
- DOI: 10.1111/irv.12892
A Sanger sequencing protocol for SARS-CoV-2 S-gene
Abstract
We describe a Sanger sequencing protocol for SARS-CoV-2 S-gene the Spike (S)-glycoprotein product of which, composed of receptor-binding (S1) and membrane fusion (S2) segments, is the target of vaccines used to combat COVID-19. The protocol can be used in laboratories with basic Sanger sequencing capabilities and allows rapid "at source" screening for SARS-CoV-2 variants, notably those of concern. The protocol has been applied for surveillance, with clinical specimens collected in either nucleic acid preservation lysis-mix or virus transport medium, and research involving cultured viruses, and can yield data of public health importance in a timely manner.
Keywords: S-gene; SARS-CoV-2; Sanger sequencing; base-calling accuracy; variant detection.
© 2021 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.
Conflict of interest statement
All authors declare no conflicts of interest.
References
-
- World Health Organization . Operational considerations for COVID‐19 surveillance using GISRS: interim guidance 2020. https://apps.who.int/iris/bitstream/handle/10665/331589/WHO-2019-nCoV-Le... Accessed July 14, 2021.
-
- World Health Organization . Preparing GISRS for the upcoming influenza seasons during the COVID‐19 pandemic—practical consideration 2020. https://apps.who.int/iris/bitstream/handle/10665/332198/WHO-2019-nCoV-Pr... Accessed July 14, 2021.
-
- Wise J. COVID‐19: new coronavirus variant is identified in UK. BMJ. 2020;37:m4857. - PubMed
-
- Tegally H, Wilkinson E, Giovanetti M, et al. Detection of a SARS‐CoV‐2 variant of concern in South Africa. Nature. 2021;592:438‐443. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
